Modern paradigm of treatment of hyperuricemia and gout in comorbid patients with the development of cardio-vascular pathology
The article presents the actuality of the problem of hyperuricemia (HU) and gout in modern medicine, caused by the high prevalence and socio-economic consequences associated with the development in patients with these pathologies of earlier and more severe course of atherosclerosis, coronary heart d...
Main Authors: | V. I. Mazurov, I. B. Belyaeva, M. S. Petrova, R. A. Bashkinov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2020-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/5922 |
Similar Items
-
Gout: objective, indications and adherence to uratelowering therapy
by: V. V. Tsurko, et al.
Published: (2019-03-01) -
Febuxostat as an effective drug of choice for urate-lowering therapy for gout (case report)
by: A. B. Bashkova, et al.
Published: (2022-08-01) -
The many faces of gout: modern treatment concepts
by: Irina N. Bobkova, et al.
Published: (2021-10-01) -
FEBUXOSTAT FOR TREATMENT OF CHRONIC HYPERURICEMIA IN GOUT PATIENTS
by: M. S. Petrova, et al.
Published: (2017-11-01) -
Current issues in the practical use of allopurinol in patients with gout and hyperuricemia
by: M. S. Eliseev
Published: (2024-10-01)